Development of apoptosis and changes in apoptosis-related genes expression in the thymus of nivalenol-treated mice

Journal of Toxicologic Pathology

Volumn 14, Issue 4, 2001, Pages 299-304

  Poapolathep, Amnart ^a   Suzuki, Kazuhiko ^a   Katayama, Kei Ichi ^a   Ohtsuka, Ryoichi ^a   Nagata, Takayuki ^a   Uetsuka, Koji ^a   Nakayama, Hiroyuki ^a   Doi, Kunio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Apoptosis; Apoptosis related genes; Mouse; Nivalenol; Thymus

Indexed keywords

EID: 0037921831     PISSN: 09149198     EISSN: 09149198     Source Type: Journal    
DOI: 10.1293/tox.14.299     Document Type: Article

References (24)

1. Placinta CM, D'Mello JPF, and Macdonald AMC. A review of worldwide contamination of cereal grains and animal feed with Fusarium mycotoxins. Anim Feed Sci Technol 1999; 78: 21-37.
2. Poapolathep A, Ohtsuka R, Kiatipattanasakul W, Ishigami N, Nakayama H, and Doi K. Nivalenol-induced apoptosis in thymus, spleen and Peyer's patch of mice. Exp Toxicol Pathol 2001; 53: in press.
3. Sentman CL, Shutter JR, Hockenbery D, Kanakawa O, and Korsmeyer SL. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 1991; 67: 879-888.
4. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, and Hancock DC. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119-128.
5. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, and Wyllie AH. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 362: 849-852.
6. Gavrieli Y, Sherman Y, and Ben-Sassan SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
7. De Torres C, Munell F, Ferrer I, Reventos J, and Macaya A. Identification of necrotic cell death by the TUNEL assay in the hypoxic ischemic neonatal rat brain. Neurosci Lett 1997; 230: 1-4
8. Lee W, Haslinger A, Karin M, and Tjian R. Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature 1987; 325: 368-372.
9. Angel P, Allegretto EA, Okino ST, Hattori K, Boyle WJ, Hunter T, and Karin M. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature 1988; 332: 166-171.
10. Franza BR, Rauscher FJ, Josephs SF, and Curran T. The fos complex and fos-related antigens recognize sequence elements that contain AP-1 binding sites. Science 1988; 239: 1150-1153.
11. Riabowol K, Schiff J, and Gilman MZ. Transcription factor AP-1 activity is required for initiation of DNA synthesis and is lost during cellular aging. Proc Natl Acad Sci 1992; 89: 157-161.
12. Carr FE, Fisher CU, Fein HG, and Smallridge RC. Thyroprotein-releasing hormone stimulates c-jun and c-fos messenger ribonucleic acid levels: Implication for calcium mobilization and protein kinase-C activation. Endocrinology 1993; 133: 1700-1707.
13. Lau LF, and Nathans D. Expression of a set of growth-related immediately early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc. Proc Natl Acad Sci 1987; 84: 1182-1186.
14. Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Miao GG, Schiling K, Robertson LM, Curran T, and Morgan JI. Continuous c-fos expression precedes programmed cell death in vivo. Nature 1993; 363: 166-169.
15. Mils V, Piette J, Barette C, Veyrune J, Tesniere A, Escot C, Guilhou JJ, and Basset-Seguin N. The proto-oncogene c-fos increases the sensitivity of keratinocytes to apoptosis. Oncogene 1997; 14: 1555-1561.
16. Shinozuka J, Tsutsui S, Ishigami N, Ueno-Yamanouchi A, Nakayama H, and Doi K. Development of apoptosis and changes in apoptosis- related genes expression in the mouse thymus following T-2 toxin-inoculation. J Toxicol Pathol 1999; 12: 77-81.
17. Colotta F, Polentarutti N, Sironi M, and Mantovani A. Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem 1992; 267: 18278-18283.
18. Yonehara S. Involvement of apoptosis antigen Fas in clonal deletion of human lymphocytes induced by superantigen. Int Immunol 1994; 6: 1849-1856.
19. Lowe SW, Ruley HE, Jacks T, and Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74: 957-967.
20. Finlay CA, Hinds PW, and Levine AJ. The p53 protooncogene can act as a suppressor of transformation. Cell 1989; 57: 1083-1093.
21. Lavin M, and Watters D. The bcl-2 oncogene regulates lymphocyte survival and potentiates lymphomagenesis. In: Programmed Cell Death, Harwood Acardemic Publishers GmbH, Netherlands, 167-178, 1993.
22. Askew DS, Ashman RA, Simmons BC, and Cleveland JL. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 1991; 6: 1915-1922.
23. Wurm FM, Gwinn KA, and Kingston RE. Inducible overproduction of the mouse c-myc protein in mammalian cells. Proc Natl Acad Sci 1986; 83: 5414-5418.
24. Albarenque SM, Suzuki K, Shinozuka J, Nakayama H, and Doi K. Kinetics of apoptosis-related genes mRNA expression in the dorsal skin of hypotrichotic WBN/ILA-Ht rats after topical application of T-2 toxin. Exp Toxicol Pathol 2001; 52: 553-556.